alexa Effect of Magnesium Sulphate on Attenuation of Hemodynamic Stress Responses during Laparoscopic Abdominal Surgeries | OMICS International
ISSN: 2155-6148
Journal of Anesthesia & Clinical Research
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Effect of Magnesium Sulphate on Attenuation of Hemodynamic Stress Responses during Laparoscopic Abdominal Surgeries

Showket Ahmad Dar*, D Das Gupta, Rajshree C Deopujari, and Prerna Gomes

Medanta the Medicity, Gurgaon, Haryana, India

*Corresponding Author:
Showket Ahmad Dar
Medanta the Medicity, Gurgaon
Haryana, India
Tel: 917835822949
E-mail: [email protected]

Received Date: October 22, 2015; Accepted Date: December 21, 2015; Published Date: December 28, 2015

Citation: Dar SA, Gupta DD, Deopujari RC, Gomes P (2015) Effect of Magnesium Sulphate on Attenuation of Hemodynamic Stress Responses during Laparoscopic Abdominal Surgeries. J Anesth Clin Res 6:590. doi: 10.4172/2155-6148.1000590

Copyright: © 2015 Dar SA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Anesthesia & Clinical Research


Introduction: This randomized, double-blind, prospective study was undertaken to evaluate the effect of magnesium sulphate in attenuating the stress responses associated with laparoscopic abdominal surgeries.

Methods: 62 patients who underwent laparoscopic abdominal surgery were randomly divided in to two groups, group I and group II. 5 minutes after intubation but before creation of pneumoperitoneum, the magnesium group (group I) received magnesium sulphate 50 mg/kg diluted in normal saline to total volume of 20 ml at 240 ml/hour over 5 minutes. The control group (group II) received same amount of normal saline.

Results: Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure were significantly less in group I with p<0.05. Train of four had no statistical significance. Extubation time was more in Group I but had no statistical significance.

Conclusion: magnesium sulphate attenuates hemodynamic stress response in laparoscopic abdominal surgeries.


Hemodynamic changes; Magnesium sulphate; Laparoscopic abdominal surgeries; Extubation time


Early in the 20th century, diagnostic laparoscopy was used by a limited number of general surgeons in place of diagnostic laparotomy, but had a substantial complication rate [1]. First laparoscopic cholecystectomy was performed by a French gynaecologist Mouret in 1987 with the help of four trocars [2].

Laparoscopic surgical procedures aim to achieve a satisfactory therapeutic result while minimizing the traumatic and metabolic stress of the intervention. Tissue trauma is significantly less than conventional open procedures, thus results in less postoperative pain. Other advantages include smaller incisional sites, lower risks of wound complications, shorter hospital stay, more rapid return to normal activities, and cost saving [3]. Pneumoperitoneum required for the smooth conduct of laparoscopy, affects homeostasis and leads to alterations in cardiovascular, pulmonary physiology and stress response. Cardiovascular changes include increase in mean arterial pressure (MAP) with no significant change in heart rate [4], decrease in cardiac output and increase in systemic vascular resistance. The mechanism of the decrease cardiac output is multifactorial [5,6].

Various surgical methods like change in nature of insufflating gas [7], use of low intra-abdominal pressure [8,9], use of abdominal wall lift methods [10], have been tried to decrease the hemodynamic alterations seen with pneumoperitoneum, but all with practical limitations. Various anaesthetic interventions like use of epidural, segmental spinal [11], combined epidural and general anesthesia [12], use of various pharmacologic interventions like nitroglycerine [13], esmolol [14], have been used with varying success and practical limitations.

Magnesium blocks release of catecholamine from both adrenergic nerve terminals and adrenal gland [15]. Intravenous magnesium sulphate inhibits catecholamine release associated with intubation [16]. Magnesium also produces vasodilatation by acting directly on blood vessels [17], and in high doses, attenuates vasopressin mediated vasoconstriction [18].

Materials and Methods

After obtaining approval from hospital Ethical Committee, details of the procedure was explained to the patients and a written informed consent was taken. 62 ASA I or II patients undergoing laparoscopic abdominal surgery were enrolled into the study. Exclusion criteria were; known allergy to any drug in study, cardiovascular disease, asthma, body weight >75 kgs, hypermagnesemia, kidney disease, endocrine and metabolic disease, diabetes mellitus, and patients on calcium channel blockers.

Patients were randomly divided into two groups according to computer generated randomization table. A patient received one of these solutions as a bolus intravenously 5 minutes after intubation but before pneumoperitoneum was created.

Group I: (Magnesium group) received magnesium sulphate 50 mg/kg 5 minutes after intubation over a period of 5 minutes diluted in normal saline to total volume 20ml @ 240 ml/hr through infusion pump but before pneumoperitoneum was created.

Group II: (control group) received 20 ml of normal saline @ 240 ml/hr through infusion pump 5 minutes after intubation over a period of 5 minutes but before pneumoperitoneum was created.

On the night prior to surgery all patients received tab Pantoprozole 40 mg & Tab Alprazolam 0.5 mg orally as premedication and patients were kept nil by mouth 6 hrs prior to surgery.

On arrival in the operating room, after confirming the identity of the patient, the consent was checked; the preoperative assessment was reviewed and up dated. The nil by mouth status of the patient was confirmed. Anesthesia machine, monitors and resuscitation equipments were checked. ECG, NIBP and pulse oximeter were applied and baseline readings of parameters like HR, SBP, DBP, MAP and SpO2 were noted. Capnometer (ETCO2) was attached after intubation.

All patients received premedication injection midazolam 0.02 mg/kg, injection fentanyl 2 µg/kg, and injection Glycopyrolate 4 µg/kg body weight intravenous.

Patients were pre-oxygenated with 100% O2 for 3 minutes before induction. Induction was done with Inj. Propofol 2 mg/kg body weight i.v in both the groups and injection Rocuronium 0.8 mg/kg iv to facilitate endotracheal intubation. Bilateral air entry was confirmed by auscultation, ETCO2 reading noted and the endotracheal tube was firmly secured using adhesive tape.

Anesthesia was maintained with oxygen and nitrous oxide mixture 50:50, sevoflurane end- tidal 1.5 to 2.5% and rocuronium 0.2 mg/kg intermittent boluses.

During surgery ringer lactate was infused in accordance with deficit, maintenance and blood loss. CO2 pneumoperitoneum was created and intra-abdominal pressure maintained between 12-14 mm Hg. Patients were ventilated mechanically. Tidal volume and respiratory rate were adjusted to maintain end-tidal CO2 between 35-45mm Hg. Monitoring of HR, SBP, DBP, MBP, SpO2, ETCO2 and TOF was done on a multi-channel monitor and TOF monitor. All patients were given injection ondanseteron 4mg, injection diclofenac sodium 75mg intravenous towards the end of surgery.

Reversal and Extubation

After completion of surgery and achieving complete haemostasis and placement of dressing at the site of surgery, residual neuromuscular blockade was reversed with a combination of Injection Neostigmine 0.05 mg/kg and Injection Glycopyrrolate 8 µg/kg. Sevoflurane and nitrous Oxide were discontinued once last suture was applied. 100% Oxygen was administered. The patients were extubated once TOF was between 90 % to 100%. Extubation time was noted. All patients were monitored for 30 minutes in recovery room following extubation.

Monitoring and recording of parameters was done at following intervals and analyzed for study.

• Baseline vitals (Average of 3 readings pre-operative).
• Five minutes after intubation.
• Five minutes after infusion of drug.
• Before creation of pneumoperitoneum.
• 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 minutes after pneumoperitoneum

Statistical Analysis

After data collection, data entry was done in Excel. Data analysis was done with the help of SPSS Software ver 15 and Sigmaplot Ver 11.

Quantitative data is presented with the help of Mean, Std Dev, Median and IQR, comparison between study groups is done with the help of Unpaired t-test or Mann-Whitney test as per results of Normality test. Qualitative data is presented with the help of Frequency and Percentage table, association among study group is assessed with the help of Chi-Square test. p-value less than 0.05 is taken as significant level.


The patient characteristics are described in table 1.

  Group I Group II
Age (yrs) 37.97 ± 10.77 38.16 ± 8.43
Weight (kg) 59.19 ± 7.62 61.77 ± 8.28
M/F  3/28  3/28

Table 1: patient characteristics.

There was no significant difference in the base line pulse rate, systolic, diastolic and mean arterial pressure (Table 2).

  Group I Group II p value
PR 91.39 ± 16.74 89.32 ± 15.18 0.613
SBP 124.35 ± 18.89 125.26 ± 15.81 0.839
DBP 78.26 ± 22.59 74.87 ± 9.56 0.445
MAP 86.81 ± 9.87 87 ± 10.14 0.94

Table 2: Baseline vitals.

Heart rate in group I was lower than group II throughout the study period but was statistically significant at 10 minutes after pneumoperitoneum (p<0.05). Systolic blood pressure, Diastolic blood pressure, Mean arterial pressure was low in group I than group II throughout the study period and were statistically significant (p<0.05) (Figures 1-4).


Figure 1: Comaprison of PR (per min) at various duaration among study group.


Figure 2: Comparison of SBP (mmHg) at various duration among study groups.


Figure 3: Comparison of DBP (mmHg) at various duration among study groups.


Figure 4: Comparison of MAP (mmHg) at various duration among study groups.

There was no statistical significant difference in TOF between the two groups. Extubation time was more in group I than group II but was not statistically significant. No case of bradycardia was noted in either group.


This placebo controlled, double blind study was designed to assess the effects of magnesium sulphate on attenuation of hemodynamic stress responses during laparoscopic abdominal surgeries.

Diamant et al. [18] reported 35% decrease in cardiac output in dog with a raised intra-abdominal pressure of 40mmHg. Ishizaki et al. [8] Tried to evaluate the safe intra-abdominal pressure duringe laparoscopic surgry. They observed significant fall in cardiac output at 16 mm Hg of intra-abdominal pressure and hemodynamic alterations. So we kept intra-abdominal in our study between 12-14 mm Hg and decided to use magnesium sulphate to attenuate hemodynamic changes during laparoscopic surgeries.

Study by Joris JL et al. [3] concluded that vasopressin and catecholamines probably mediate the increase in systemic vascular resistance observed during pneumoperitoneum. Magnesium sulphate is effective in blocking the release of catecholamines from both adrenergic nerve terminals and the adrenal gland. Besides, magnesium produces vasodilatation by acting directly on blood vessels. Magnesium also attenuate vasopressin stimulated vasoconstriction. Because of the ability of magnesium sulphate to attenuate adverse hemodynamic response, we have administered 50 mg/kg magnesium sulphate as an infusion over 5 minutes. The same dosage has been used by Nand Kishore Kalra et al. [19], Deokhee Lee et al., [20] and D Jee et al. [21] in their studies.

Heart rate was low in group I throughout the study period compared to group II but was statistically significant at 10 minutes after pneumoperitoneum (80.52 ± 15.86 vs 89.87± 14.84) which was similar as reported by Suhrita Paul et al. [22], Manjushree Ray et al. [23], TO Seyhan et al., [24] Ryu JH et al., [25] and Y Nakaigawa et al. [26].

In our study systolic blood pressure was low in group I compared to group II with statistical significance at before pneumoperitoneum (97.68 ± 10.74 verses 107.16 ± 18.34 with p=0.016), 5 minutes after pneumoperitoneum (98.55 ± 11.64 verses 107.42 ± 16.03 with p=0.015), 10 minutes after pneumoperitoneum (102.45 ± 12.17 verses 114.13 ± 19.42 with p=0.006), 15 minutes after PP (105.06 ± 10.14 verses 116.35 ± 20.29 with p=0.007), 20 minutes after PP (100.71 ± 9.29 verses 115.61 ± 22.83 with p=0.001), 25 minutes after PP (99.97 ± 10.70 verses 113.00 ±17.99 with p=0.001), 30 minutes after PP (101.61 ± 9.78 verses 109.84 ± 18.79 with p=0.035), 35 minutes after PP (101.45 ± 11.31 verses 110.68 ± 18.58 with p=0.021), 40 minutes after PP (102.32 ± 9.08 verses 112.55 ± 20.86 with p=0.015), 45 minutes after PP (101.29 ± 10.86 verses 110.13 ± 18.27 with p=0.024), 50 minutes after PP (100.55 ± 13.09 verses 111.06 ± 17.72 with p=0.010), 55minutes after PP (100.71 ± 12.06 verses 111.39 ± 18.13 with p=0.008), and 60 minutes after PP (103.87 ± 11.72 verses 113.19 ± 14.86 with p=0.008).

Diastolic blood pressure was lower in group I than group II with statistical significance at 5 minutes after infusion of drug (60.00 ± 14.22 mm Hg verses 68.74 ± 14.14 mm Hg with p=0.018), before pneumoperitoneum (60.32 ± 11.86 mm Hg verses 68.94 ± 15.42 mm Hg with p=0.017), 10 minutes after pneumoperitoneum (65.94 ± 13.05 mm Hg verses 74.29 ± 14.27 mm Hg with p=0.019), 15 minutes after pneumoperitoneum (68.03 ± 9.84 mm Hg verses 76.71 ± 11.56 mm Hg with p=0.002), 20 minutes after PP (66.03 ± 9.98 mm Hg verses 72.97 ± 13.38 mm Hg with p=0.024), 25 minutes after PP (65.32 ± 10.35 mm Hg verses 74.42 ± 12.77 mm Hg with p=0.003), and 55 minutes after PP (67.45 ± 9.25 mm Hg verses 72.52 ± 10.43 mm Hg with p=0.048).

Mean arterial pressure was also lower in group I than in group II with statistical significance at 5 minutes after infusion of drug (70.16 ± 14.87 mm Hg verses 79.65 ± 14.36 mm Hg with p=0.013), 10 minutes after pneumoperitoneum (74.71 ± 12.43 mm Hg verses 84.16 ± 14.34 mm Hg with p=0.007), 15 minutes of PP (77.10 ± 9.59 mm Hg verses 86.26 ± 11.75 mm Hg with p=0.001), 20 minutes after PP (74.68 ± 10.27 mm Hg verses 81.90 ± 13.11 mm Hg with p=0.019), 25 minutes after PP (73.81 ± 10.04 mm Hg verses 83.74 ± 12.34 mm Hg with p=0.001), 50 minutes after PP (74.71 ± 10.42 mm Hg verses 81.26 ± 11.79 mm Hg with p=0.024), 55 minutes after PP (75.68 ± 10.55 mm Hg verses 81.74 ± 11.02 mm Hg with p=0.031), and 60 minutes after PP (76.84 ± 11.67mm Hg verses 82.26 ± 7.95 mm Hg with p=0.037).

D Jee et at. [28] Nand Kishore Kalra et al. [20] Y. Nakaigawa et al. [27] S. Rajan et al. [29] Deokhee Lee et al. [21] Suhrita Paul et al. [23] Manjushree Ray et al. [24] have also observed similar results.

TOF was comparable in two groups in our study. Sang-Hun Kim et al. [29] have observed results similar to our study.

Extubation time was longer in group I compared to group II. In group I extubation time was 5.77 ± 1.12 minutes verses 5.48 ± 1.23 minutes in group II but this difference has no statistical significance with p=0.346. Nand Kishore Kalra et al. [19], TO Seyhan et al. [24] have observed similar results in their studies.

We concluded from our study that use of magnesium sulphate attenuates hemodynamic stress response in laparoscopic abdominal surgeries, magnesium sulphate does not prolong neuromuscular block with single bolus dose, and under strict TOF monitoring. Magnesium sulphate may prolong extubation time but has no adverse effects on patients.


1: We have included both abdomino-pelvic cases together as the positioning of patients is different during surgery which may affect study parameters.

2: Only ASA I score patients were included.

3: Small cohort size.

4: we have not done invasive hemodynamic monitoring to see the effects on SVR, and cardiac output.


  1. Vecchio R, MacFayden BV, Palazzo F (2000) History of laparoscopic surgery.  Panminerva Med 42: 87-90.
  2. Nicholson ML, Elwell R, Kaushik M, Bagul A, Hosgood SA (2011) Healthrelated quality of life after living donar nephrectomy: a randomised controlled trial of laparoscopic verses open nephrectomy. Transplantation 91: 457-461.
  3. Joris JL, Chiche JD, Canivet JL, Jacquet NJ, Legros JJ, et al. (1998) Hemodynamic changes induced by laparoscopy and their endocrine correlates: effects of clonidine.  J Am CollCardiol 32: 1389-1396.
  4. Sharma KC, Brandstetter RD, Brensilver JM, Jung LD (1996) Cardiopulmonary physiology and pathophysiology as a consequence of laparoscopic surgery.  Chest 110: 810-815.
  5. Millers Anesthesia Chapter 68-Anaesthesia for laparoscopic surgery.
  6. Menes T, Spivak H (2000) Laparoscopy: searching for the proper insufflation gas.  SurgEndosc 14: 1050-1056.
  7. Dexter SP, Vucevic M, Gibson J, McMahon MJ (1999) Hemodynamic consequences of high- and low-pressure capnoperitoneum during laparoscopic cholecystectomy.  SurgEndosc 13: 376-381.
  8. Ishizaki Y, Bandai Y, Shimomura K, Abe H, Ohtomo Y, et al. (1993) Safe intraabdominal pressure of carbon dioxide pneumoperitoneum during laparoscopic surgery.  Surgery 114: 549-554.
  9. Gurusamy KS, Koti R, Davidson BR (2013) Abdominal lift for laparoscopic cholecystectomy. Cochrane database Syst Rev 16: CD00657.
  10. van Zundert AAJ, Stulties G, Jakimowicz JJ, Peek D, van der Ham WG, et al. (2007) Laparoscopic cholecystectomy under segmental thoracic spinal anaesthesia: a feasibility study. Br J Anaesth 98: 682-686.
  11. Youssef MA, saleh Al-Mulhim A (2007) Effects of different anaesthetic techniques on antidiuretic harmone secretion during laparoscopic cholecystectomy. SurgEndosc 21: 1543-1548.
  12. Feig BW, Berger DH, Dougherty TB, Dupuis JF, Hsi B, et al. (1994) Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy.  Surgery 116: 733-739.
  13. Koivusalo AM, Scheinin M, Tikkanen I, Yli-Suomu T, Ristkari S, et al. (1998) Effects of esmolol on haemodynamic response to CO2 pneumoperitoneum for laparoscopic surgery.  ActaAnaesthesiolScand 42: 510-517.
  14. Charlson ME, MacKenzie CR, Gold JP, Ales KL, Topkins M, et al. (1989) The preoperative and intraoperative hemodynamic predictors of postoperative myocardial infarction or ischemia in patients undergoing noncardiac surgery.  Ann Surg 210: 637-648.
  15. Thwaites CL, Yen LM, Cordon SM, Thwaites GE, Loan HT, et al. (2008) Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus.  Anaesthesia 63: 719-725.
  16. James MF, Cork RC, Dennett JE (1987) Cardiovascular effects of magnesium sulphate in the baboon.  Magnesium 6: 314-324.
  17. Pritchard JA, Pritchard SA (1975) Standardized treatment of 154 consecutive cases of eclampsia.  Am J ObstetGynecol 123: 543-552.
  18. Diamant M, Benumof JL, Saidman LJ (1978) Hemodynamics of increased intra-abdominal pressure: Interaction with hypovolemia and halothane anesthesia.  Anesthesiology 48: 23-27.
  19. Kalra NK, Verma A, Agarwal A, Pandy H (2011) Comparative study of intravenously administered clonidine and magnesium sulphate on hemodynamic responses during laparoscopic cholecystectomy. J AnaesthesiolClinPharmocol 27: 344-348.
  20. Lee D, Jee D, Yun S (2007) Intravenous magnesium sulphate attenuates hemodynamic responses in laparoscopic cholecystectomy. Anaesthesiology 107:A516.
  21. Ossama HA, EI-Shaaraway AM, Omar AM, Abdelwahab HH (2011) A comparative study between magnesium sulphate and dexmedetomidine for deliberate hypotension during middle ear surgery. Egypt J Anaesth 27: 227-232.
  22. Paul S, Biswas P, Bhattacharjee DP, Sengupta J (2013) Effects of magnesium sulphate on hemodynamic response to carbon dioxide pneumoperitoneum in patients undergoing laparoscopic cholecystectomy. Anaesthesia Essays and Researchs. 7: 228-231.
  23. Ray M, Bhattacharjese DP, Hajra B, Pal R, Chatterjee N (2006) Effect of clonidine and magnesium sulphate on anaesthetic consumption, haemodynamics, and postoperative recovery: A comparative study. Indian Journal Anaesth. 54: 137-41.
  24. Seyhan TO, Tugrul M, Sungur MO, Kayacan S, Telci L, et al. (2006) Effects of three different dose regimens of magnesium on propofol requirements, hemodynamic variables and post operative pain relief in gynaelogical surgery. British Journal of Anaesthesia 96: 247-52.
  25. Ryu JH, Sohn IS, Do SH (2009) Controlled hypotension for middle ear surgery: a comparison between remifentanil and magnesium sulphate.  Br J Anaesth 103: 490-495.
  26. Nakaigawa Y, Akazawa S, Shimizu R, Ishii R, Ikeno S, et al. (1997) Effects of magnesium sulphate on the cardiovascular system, coronary circulation and myocardial metabolism in anaesthetized dogs.  Br J Anaesth 79: 363-368.
  27. Jee D, Lee D, Yun S, Lee C (2009) Magnesium sulphate attenuates arterial pressure increase during laparoscopic cholecystectomy. British Journal of Anaesthesia 103(4):484-9.
  28. Rajan S, Kavita M, Andrews S (2012) The attenuating effects of magnesium on hemodynamic responses during transnasaltranssphenoidal surgery. Amrita Journal of Medicine. Page 31-35.
  29. Kim SH, So KY, Jung KT (2012) Effect of magnesium sulfate pretreatment on onset and recovery characteristics of cisatracurium.  Korean J Anesthesiol 62: 518-523.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 8511
  • [From(publication date):
    December-2015 - Mar 24, 2018]
  • Breakdown by view type
  • HTML page views : 8317
  • PDF downloads : 194

Review summary

  1. Wendy Keith
    Posted on Aug 31 2016 at 2:36 pm
    The article discusses the role of magnesium sulphate in attenuating the stress response in cases of patients who underwent laproscopic abdominal surgeries. The authors also conducted statistical analyses of the changes in various factors associated with stress such as heart rate and blood pressure.

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version